Alpha 2.0
Login Register
» Articles » PMID: 16961623

Von Willebrand Factor Collagen Binding Assay in Von Willebrand Disease Type 2A, 2B, and 2M

Overview
Journal J Thromb Haemost
Publisher Elsevier
Specialty Hematology
Date 2006 Sep 12
PMID 16961623
Citations 4
Authors
L Baronciani
A B Federici
G Cozzi
M T Canciani
P M Mannucci
Affiliations
Soon will be listed here.
Citing Articles

New advances in the diagnosis of von Willebrand disease.

Sharma R, Haberichter S Hematology Am Soc Hematol Educ Program. 2019; 2019(1):596-600.

PMID: 31808831 PMC: 6913428. DOI: 10.1182/hematology.2019000064.

The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.

Machha V, Tischer A, Moon-Tasson L, Auton M J Mol Biol. 2016; 429(1):32-47.

PMID: 27889474 PMC: 5186406. DOI: 10.1016/j.jmb.2016.11.014.

Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.

Ni Y, Nesrallah J, Agnew M, Geske F, Favaloro E Int J Lab Hematol. 2012; 35(2):170-6.

PMID: 23107512 PMC: 3617461. DOI: 10.1111/ijlh.12019.

Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.

Pruss C, Golder M, Bryant A, Hegadorn C, Haberichter S, Lillicrap D J Thromb Haemost. 2012; 10(5):940-50.

PMID: 22372972 PMC: 5962034. DOI: 10.1111/j.1538-7836.2012.04675.x.